A woman in midlife talking with her doctor during an appointment

Why Perimenopause Is So Hard to Diagnose

One of the most frustrating things about perimenopause is that there is no single test that says "yes, this is it." Many women arrive at a doctor's office with a fistful of symptoms, ask for a blood test to confirm what's happening, and leave more confused than they came. Understanding why it's hard to pin down is the first step to advocating for yourself.

The blood test that can't settle it

The obvious candidate is FSH (follicle-stimulating hormone), which rises as ovaries wind down. The problem: in perimenopause, hormones don't decline in a tidy line — they swing. FSH and estrogen can bounce week to week, so a single blood draw is only a snapshot of one moment in a moving picture. A "normal" result on a given day does not rule perimenopause out.

That's why recent clinical guidance recommends not using FSH tests to diagnose the transition in women aged 45 and over. In that age group, the test adds little the symptoms don't already tell you — and can actively mislead.

In perimenopause, hormones swing rather than decline in a line — so a single blood test is a snapshot of a moving picture.

How doctors actually stage it

The closest thing to a standard is the STRAW+10 system (Stages of Reproductive Aging Workshop), the widely used research framework. Notably, it leans mainly on menstrual-cycle patterns, not lab tests. Early perimenopause is marked by cycle lengths that start to differ by seven or more days from one cycle to the next; late perimenopause by gaps of 60 days or more between periods. Hormone levels are only a supporting clue, not the headline.

Even the framework has limits

Here's the honest frontier: STRAW+10 is built around menstrual-cycle changes, but plenty of women have disrupting symptoms — hot flashes, sleep and mood changes — before their cycles shift in the textbook way, or while on contraception that masks the pattern entirely. In 2025, findings from the Australian Women's Midlife Years (AMY) Study, published in The Lancet Diabetes & Endocrinology, argued that the current staging approach doesn't serve perimenopause well and that symptoms — especially vasomotor symptoms and changes in flow — may be more clinically useful than calendar-based rules.

What this means for you

The takeaway isn't that perimenopause is unknowable — it's that you hold the most useful data. Because diagnosis rests on patterns over time, a running record of your cycles and symptoms is often more revealing than any one lab result. Tracking turns a vague "I don't feel right" into the concrete picture a clinician can actually stage and act on — which is exactly what PeriShift is built to help you do.

This article is for general information and is not medical advice. Talk with a qualified clinician about your symptoms and diagnosis.

Sources

PeriShift starts with a 30-day free trial on Android. No account. No cloud. Your data stays on your phone.

Get PeriShift on Google Play →